CHARGE consortium: gene discovery for CVD and aging phenotypes
CHARGE consortium: gene discovery for CVD and aging phenotypes
批准号:
8402649
负责人:
Bruce M Psaty
金额:
$63.66万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-02-15 至 2015-03-31
关键词:
AbbreviationsAgingApplications GrantsAtherosclerosisBody CompositionCardiovascular DiseasesCardiovascular systemCohort StudiesCollaborationsCommunitiesComplexCoronary arteryDNADataDevelopmentDiabetes MellitusDiseaseElementsEnvironmentEpidemiologyEventFosteringFramingham Heart StudyFutureGeneticGenomicsGenotypeHealthHeartIncentivesInternationalLaboratoriesLeadLipidsManuscriptsMeasuresMeta-AnalysisNon-Insulin-Dependent Diabetes MellitusPaperParticipantPhenotypePostdoctoral FellowPredispositionPreventionProcessPublicationsPublishingResearchResearch DesignResearch PersonnelResourcesRiskRisk FactorsRoleSample SizeScienceScientistSiteStructureStudentsTestingTexasTimeTrainingUniversitiesWorkaging genecardiovascular disorder epidemiologycohortdoctoral studentfollow-upgene discoverygenetic variantgenome wide association studygenome-wideimprovedinnovationmeetingsoperationorganizational structurepopulation basedprospectivepublic health relevancesymposiumweb sitewikiworking groupyoung adult
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Recently, consortia of genome-wide association studies (GWAS) have formed around specific phenotypes such as type 2 diabetes and lipids to identify associations with genetic variants. In contrast, the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium was formed in Feb 2008 to facilitate GWAS prospective meta-analyses of a wide range of phenotypes among large population-based cohort studies, including the Age, Gene/Environment Susceptibility Study, Atherosclerosis Risk in Communities Study, Cardiovascular Health Study, Framingham Heart Study, and the Rotterdam Study. The Health Aging and Body Composition Study, Multi-Ethnic Study of Atherosclerosis, and Coronary Artery Risk Development in Young Adults Study are now participating as well. With more than 53,000 participants, these cohort studies have both genome-wide data and repeated measures of risk factors, subclinical disease measures, and cardiovascular events all collected in a standardized fashion. The CHARGE collaboration, which takes advantage of the hundreds of millions of dollars already invested in these cohort studies, represents a major innovation in consortium structure because the organizing principle is the cohort study design rather than the phenotype. In just over a year and a half of collaboration, the CHARGE investigators have 21 papers published or in press, 14 papers under review, and about 50 other analyses or papers in progress. The CHARGE consortium represents an unfunded voluntary federation of large complex studies, one that lacks infra-structural support to sustain its increasingly complex operations. The two functions that none of the cohorts can offer in a sustained way are: 1) administrative Coordinating-Center-like support for working groups, committees, conference calls, meetings, tracking publications, and upgrades to the website and wiki; and 2) modest genotyping resources for follow-up and replication efforts often required by editors and reviewers. In the proposed R01, we plan to provide not only Coordinating-Center support and modest genotyping resources, but also support for students, fellows and junior investigators, including new opportunities for junior investigators from one site to spend time working at another site (exchanges). Junior investigators have often taken a leading role in CHARGE analyses and manuscripts with the result that the CHARGE consortium has become a kind of de facto international training ground for collaborative epidemiological efforts in the genetics of aging and cardiovascular disease. All CHARGE papers have junior investigators among the set of investigators identified as contributing equally as first authors. First-first authors of CHARGE meta-analysis papers have frequently been doctoral students (n=4), post-doctoral fellows (n=2), or junior investigators (n=5). Support for students and junior investigators and support for between-cohort exchanges will foster collaboration, enhance the current science, and improve the training of our future scientists.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Innate and adaptive immune-cell densities as risk factors for heart failure
-
批准号:10226411
-
项目类别:
-
资助金额:$67.73万
-
财政年份:2018
-
负责人:Bruce M Psaty
-
依托单位:
Rare variants and NHLBI traits in deeply phenotyped cohorts
-
批准号:8683958
-
项目类别:
-
资助金额:$76.28万
-
财政年份:2014
-
负责人:Bruce M Psaty
-
依托单位:
Rare variants and NHLBI traits in deeply phenotyped cohorts
-
批准号:8930265
-
项目类别:
-
资助金额:$141.6万
-
财政年份:2014
-
负责人:Bruce M Psaty
-
依托单位:
Rare variants and NHLBI traits in deeply phenotyped cohorts
-
批准号:9334955
-
项目类别:
-
资助金额:$300.0万
-
财政年份:2014
-
负责人:Bruce M Psaty
-
依托单位:
T-cell subsets as CVD risk factors in CHS and MESA
-
批准号:8890872
-
项目类别:
-
资助金额:$70.8万
-
财政年份:2014
-
负责人:Bruce M Psaty
-
依托单位:
Rare variants and NHLBI traits in deeply phenotyped cohorts
-
批准号:9034657
-
项目类别:
-
资助金额:$69.05万
-
财政年份:2014
-
负责人:Bruce M Psaty
-
依托单位:
T-cell subsets as CVD risk factors in CHS and MESA
-
批准号:9055750
-
项目类别:
-
资助金额:$63.52万
-
财政年份:2014
-
负责人:Bruce M Psaty
-
依托单位:
T-cell subsets as CVD risk factors in CHS and MESA
-
批准号:8755241
-
项目类别:
-
资助金额:$72.66万
-
财政年份:2014
-
负责人:Bruce M Psaty
-
依托单位:
Prospective meta-analyses of drug-gene interactions: CHARGE GWAS consortium
-
批准号:8105534
-
项目类别:
-
资助金额:$139.82万
-
财政年份:2011
-
负责人:Bruce M Psaty
-
依托单位:
Prospective meta-analyses of drug-gene interactions: CHARGE GWAS consortium
-
批准号:8470694
-
项目类别:
-
资助金额:$129.04万
-
财政年份:2011
-
负责人:Bruce M Psaty
-
依托单位:
CHARGE consortium: gene discovery for CVD and aging phenotypes
-
批准号:9001355
-
项目类别:
-
资助金额:$66.86万
-
财政年份:2011
-
负责人:Bruce M Psaty
-
依托单位:
CHARGE consortium: omics discovery for CVD and aging phenotypes
-
批准号:10669243
-
项目类别:
-
资助金额:$60.41万
-
财政年份:2011
-
负责人:Bruce M Psaty
-
依托单位:
CHARGE consortium: gene discovery for CVD and aging phenotypes
-
批准号:8810073
-
项目类别:
-
资助金额:$71.99万
-
财政年份:2011
-
负责人:Bruce M Psaty
-
依托单位:
CHARGE consortium: gene discovery for CVD and aging phenotypes
-
批准号:8023579
-
项目类别:
-
资助金额:$71.48万
-
财政年份:2011
-
负责人:Bruce M Psaty
-
依托单位:
CHARGE consortium: gene discovery for CVD and aging phenotypes
-
批准号:8230469
-
项目类别:
-
资助金额:$66.89万
-
财政年份:2011
-
负责人:Bruce M Psaty
-
依托单位:
CHARGE consortium: gene discovery for CVD and aging phenotypes
-
批准号:9977252
-
项目类别:
-
资助金额:$67.66万
-
财政年份:2011
-
负责人:Bruce M Psaty
-
依托单位:
Prospective meta-analyses of drug-gene interactions: CHARGE GWAS consortium
-
批准号:8318660
-
项目类别:
-
资助金额:$134.19万
-
财政年份:2011
-
负责人:Bruce M Psaty
-
依托单位:
CHARGE consortium: gene discovery for CVD and aging phenotypes
-
批准号:10215276
-
项目类别:
-
资助金额:$67.53万
-
财政年份:2011
-
负责人:Bruce M Psaty
-
依托单位:
Prospective meta-analyses of drug-gene interactions: CHARGE GWAS consortium
-
批准号:8668128
-
项目类别:
-
资助金额:$134.45万
-
财政年份:2011
-
负责人:Bruce M Psaty
-
依托单位:
Genome-wide case-only study of antihypertensive drug-gene interactions
-
批准号:7494142
-
项目类别:
-
资助金额:$182.86万
-
财政年份:2007
-
负责人:Bruce M Psaty
-
依托单位:
海外基金